AKT1 and cancer: It has been observed that DOX primarily affects the cancer pathway, the repressor/activator protein 1 (RAP1) and the mitogen-activated protein kinase (MAPK) pathway, and then the RAS and phosphotidyl inositol-3-phosphate-Akt pathway.